Concepedia

Dale P. Conner

DP

Statistics

Publications

35

Citations

2.6K

H-Index

23

Active since

1985

Affiliations

United States Food and Drug Administration(Current)

Center for Drug Evaluation and Research

Uniformed Services University of the Health Sciences

University of Kansas

Pfizer (United States)

Dale P. Conner is an author at United States Food and Drug Administration specializing in pharmacology, pharmacy, and pharmacokinetics.

Publications per year

1985–2019

35

Publications

35

Biopharmaceutics Classification System: The Scientific Basis for Biowaiver Extensions

Lawrence X. Yu, Gordon L. Amidon, James E. Polli et al. · Pharmaceutical Research · 2002 · 565 citations · Full text

, , +11

Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin

Peter K. Honig, Raymond L. Woosley, Kaveh Zamani et al. · Clinical Pharmacology & Therapeutics · 1992 · 367 citations

, , +13

Dissolution Testing for Generic Drugs: An FDA Perspective

Om Anand, Lawrence X. Yu, Dale P. Conner et al. · The AAPS Journal · 2011 · 270 citations · Full text

, , +14

Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications

Barbara M. Davit, Dale P. Conner, Beth Fabian-Fritsch et al. · The AAPS Journal · 2008 · 129 citations · Full text

, , +16

Summary workshop report: Biopharmaceutics classification system—implementation challenges and extension opportunities

James E. Polli, Lawrence X. Yu, Jack Cook et al. · Journal of Pharmaceutical Sciences · 2004 · 122 citations

, , +9

1–5 of 35